Prostate

Prof. Michael Marberger, MD: Advances in Advanced Prostate Cancer from EMCC 2011
Oct
23
2011

Prof. Michael Marberger, MD, FRCS discusses the highlights in advanced prostate cancer therapy treatments at the 2011 European Multidisciplinary Cancer Conference in Stockholm. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in part, by:   VIDEO TRANSCRIPT Selma Schimmel, Founder & CEO, Vital Options International: This is Selma Schimmel at [...]

Read More
Prof. Per-Anders Abrahamsson, MD: Prostate Cancer Highlights from EMCC 2011
Oct
22
2011

Prof. Per-Anders Abrahamsson, MD discusses the highlights in prostate cancer at the 2011 European Multidisciplinary Cancer Conference in Stockholm. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in part, by: VIDEO TRANSCRIPT Selma Schimmel, Founder & CEO, Vital Options International: This is Selma Schimmel at the Multidisciplinary Cancer Congress 2011 [...]

Read More
Prof. Per-Anders Ambrahamsson, MD: What European Men Need to Know About Prostate Cancer
Oct
21
2011

Prof. Per-Anders Abrahamsson, MD discusses the lack of standardized screening guidelines for prostate cancer in Europe and around the world. He also talks about how the advocate community can help spread the word and educate men and women about prostate cancer. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in [...]

Read More
David I. Quinn, MD: Prostate Cancer Screening Update from ASCO 2011
Jun
27
2011

David I. Quinn, MD is Associate Professor of Medicine at University of Southern California (USC) Keck School of Medicine and the Medical Director, USC Norris Cancer Hospital. Dr. Quinn gives an update on prostate cancer screening from ASCO 2011. The Group Room at the 2011 American Association For Cancer Research Annual Meeting was made possible, [...]

Read More
David I. Quinn, MD: Circulating Tumor Cells and Prostate Cancer from ASCO 2011
Jun
27
2011

David I. Quinn, MD is Associate Professor of Medicine at University of Southern California (USC) Keck School of Medicine and the Medical Director, USC Norris Cancer Hospital. Dr. Quinn discusses the role of circulating tumor cells for prostate cancer treatment at ASCO 2011. The Group Room at the 2011 American Association For Cancer Research Annual [...]

Read More
David I. Quinn, MD: Advances in Prostate Cancer Treatment from ASCO 2011
Jun
27
2011

David I. Quinn, MD is Associate Professor of Medicine at University of Southern California (USC) Keck School of Medicine and the Medical Director, USC Norris Cancer Hospital. Dr. Quinn gives an update on prostate cancer treatments from ASCO 2011. The Group Room at the 2011 American Association For Cancer Research Annual Meeting was made possible, [...]

Read More
Ask Selma!
Jan
18
2009

Q. Hello Selma! My dad was diagnosed with prostate cancer in the early stages but after his prostate was removed he still had a reading. For the past several years he has been taking hormone therapy. What I do not understand is why isn’t cancer left over from prostate removal treated with radiotherapy or seed [...]

Read More